A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization

Clinical trial NCT02533791 · COMPLETED

Trial details

NCT number: NCT02533791
Sponsor: Jiangsu Province Centers for Disease Control and Prevention
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ebola Virus Disease

Start date: 2015-07-01
Primary completion: 2015-09-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.